IP Verse

Glaxosmithkline vs. Moderna - UPC_CFI_0001439/2025

The case UPC_CFI_0001439/2025 was filed by the plaintiff Glaxosmithkline Biologicals against the defendant Moderna on 06 Nov, 2025.

Case Timeline

06 Nov, 2025
Case Filed
06 Nov, 2025
Statement of Defence
06 Nov, 2025
Counterclaim for Revocation
21 Jan, 2026
Written Procedure
Today Mar 30, 2026
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_0001439/2025

    Patent Number:

    EP2590626

    Filing Date:

    06 Nov, 2025

    Proceeding Type:

    Counter Claim For Revocation

    Case Phase:

    Written Phase

    Plaintiffs:

    • Glaxosmithkline Biologicals

    Plaintiff Representative:

    • Tjibbe Douma

    Defendants:

    • Moderna
    • Moderna Belgium
    • Moderna Biotech Distributor UK
    • Moderna Biotech Spain
    • Moderna Biotech UK
    • Moderna France Sasu
    • Moderna Germany
    • Moderna Italy
    • Moderna Netherlands
    • Moderna Norway
    • Moderna Poland SP ZOO
    • Moderna Portugal Unipessoal LDA
    • Moderna Sweden
    • Moderna Switzerland
    • Modernatx

    Defendant Representative:

    • Gertjan Kuipers

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Martin Schmidt
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Mar 26, 2026
DateTitle

Notify me when new UPC document is filed

Mar 13, 2026Receipt
Mar 13, 2026Exhibit Claimant
Mar 13, 2026Cover Sheet
Mar 13, 2026Counterclaim Reply
Feb 25, 2026Receipt
Feb 25, 2026Document Claimant
Feb 25, 2026Cover Sheet
Feb 19, 2026Action.Publishorderdecision
Feb 18, 2026Order
Feb 18, 2026Action.Issueorder
Jan 28, 2026Receipt
Jan 28, 2026Other Document Defendant
Jan 28, 2026Cover Sheet
Jan 21, 2026Receipt
Jan 21, 2026Other Document Claimant
Jan 21, 2026Cover Sheet
Jan 21, 2026Action.Communication
Jan 14, 2026Receipt
Jan 14, 2026Document
Jan 14, 2026Cover Sheet
Jan 14, 2026Action.Communication
Jan 7, 2026Action.Communication
Jan 6, 2026Receipt
Jan 6, 2026Exhibit Document Defendant
Jan 6, 2026Cover Sheet
Jan 6, 2026Counterclaim Defence With Amend Patent
Jan 6, 2026Application Document Defendant
Nov 12, 2025Receipt
Nov 12, 2025Exhibit Document Claimant
Nov 12, 2025Cover Sheet
Nov 12, 2025Application Document Claimant
Nov 6, 2025Receipt
Nov 6, 2025Formal Deficiency Found
Nov 6, 2025Cover Sheet
Nov 6, 2025Counterclaim For Revocation
Nov 6, 2025Action.Communication
Nov 4, 2025Statement Of Defence
Nov 4, 2025Receipt
Nov 4, 2025Proof Of Payment
Nov 4, 2025Fee
Nov 4, 2025Exhibit Document Defendant
Nov 4, 2025Cover Sheet
Nov 4, 2025Counterclaim For Revocation

More cases involving EP2590626B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Mar 26, 2026
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna
ACT_32120/2025Jul 3, 2025GlaxosmithklineModerna
ACT_32214/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg, CP Pharmaceuticals CV, Pfizer

More cases involving Glaxosmithkline

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Mar 26, 2026
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna
APP_33242/2025Jul 21, 2025Glaxosmithkline -
APP_33256/2025Jul 21, 2025Glaxosmithkline -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Mar 26, 2026
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna
ORD_34390/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
ORD_34391/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna